CUSIP: 03152W109
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
316,644,581
-
Total 13F shares
-
273,274,367
-
Share change
-
+4,357,359
-
Total reported value
-
$2,191,232,241
-
Put/Call ratio
-
28%
-
Price per share
-
$8.02
-
Number of holders
-
195
-
Value change
-
+$7,544,973
-
Number of buys
-
115
-
Number of sells
-
88
Security key
03152W109
Report period
Q3 2019
Institutions
195
Top holders
10
Reporting periods
Holder history for CUSIP 03152W109
Recent filing periods:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2019
As of 30 Sep 2019,
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
273,274,367 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., STATE STREET CORP, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, and JENNISON ASSOCIATES LLC.
This page lists
195
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2019 vs Q2 2019 Across Filers
| Investor |
Q2 2019 Shares |
Q3 2019 Shares |
Share Diff |
Share Chg % |
Q2 2019 Value $ |
Q3 2019 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.